Future perspectives of nanoparticle-based contrast agents for cardiac magnetic resonance in myocardial infarction

Anna Maria Grimaldi, Ernesto Forte, Teresa Infante, Carlo Cavaliere, Marco Salvatore, Filippo Cademartiri

Research output: Contribution to journalReview articlepeer-review

Abstract

Cardiac Magnetic Resonance (CMR), thanks to high spatial resolution and absence of ionizing radiation, has been widely used in myocardial infarction (MI) assessment to evaluate cardiac structure, function, perfusion and viability. Nevertheless, it suffers from limitations in tissue and assessment of myocardial pathophysiological changes subsequent to MI. In this issue, nanoparticle-based contrast agents offer the possibility to track biological processes at cellular and molecular level underlying the various phases of MI, infarct healing and tissue repair. In this paper, first we examine the conventional CMR protocol and its findings in MI patients. Next, we looked at how nanoparticles can help in the imaging of MI and give an overview of the major approaches currently explored. Based on the presentation of successful nanoparticle applications as contrast agents (CAs) in preclinical and clinical models, we discuss promises and outstanding challenges facing the field of CMR in MI, their translational potential and clinical application.

Original languageEnglish
Pages (from-to)329-341
Number of pages13
JournalNanomedicine: Nanotechnology, Biology, and Medicine
Volume17
DOIs
Publication statusPublished - Apr 2019

Keywords

  • Cardiac magnetic resonance
  • Contrast agent
  • Myocardial infarction
  • Nanoparticle

ASJC Scopus subject areas

  • Bioengineering
  • Medicine (miscellaneous)
  • Molecular Medicine
  • Biomedical Engineering
  • Materials Science(all)
  • Pharmaceutical Science

Fingerprint Dive into the research topics of 'Future perspectives of nanoparticle-based contrast agents for cardiac magnetic resonance in myocardial infarction'. Together they form a unique fingerprint.

Cite this